Symbol
| DTNBP1
| contributors: mct - updated : 20-09-2022
|
HGNC name
| dystrobrevin binding protein 1
|
HGNC id
| 17328
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
| --low
|  
|
in dorsolateral prefrontal cortex and hippocampus of schizophrenic patients | constitutional
|  
|  
| --low
|  
|
in brain areas of schizophrenic patients | constitutional
|  
|  
| --low
|  
|
in the hippocampus and prefrontal cortex in post mortem brains of schizophrenic patients | |
Susceptibility
|
to schizophrenia (rs1011313) to intelligence variation to bipolar disorder to temporal lobe epilepsy (TLE) |
Variant & Polymorphism
SNP
| influencing intelligence variation |
|
association of schizophrenia with SNPs at the 3' end of DTNBP1 |
|
haplotype increasing the risk of bipolar disorder |
|
mutant allele rs2619538 T > A was exclusively observed in TLE patients |
|
|
Candidate gene
| candidate gene for SCZD3 |
Marker
Therapy target
| | |
| Sandy (sdy) mice that express no dysbindin, owing to a deletion of the DTNBP1 gene showed behavioral abnormalities such as reduced activity, heightened anxiety-like response, and deficits in social interaction, memory, and learning |